BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Surve MV, Bhutda S, Datey A, Anil A, Rawat S, Pushpakaran A, Singh D, Kim KS, Chakravortty D, Banerjee A. Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking. PLoS Pathog 2018;14:e1007168. [PMID: 30011336 DOI: 10.1371/journal.ppat.1007168] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Surve MV, Banerjee A. Cell-to-cell phenotypic heterogeneity in pneumococcal pathogenesis. Future Microbiol 2019;14:647-51. [PMID: 31148481 DOI: 10.2217/fmb-2019-0096] [Reference Citation Analysis]
2 Anil A, Apte S, Joseph J, Parthasarathy A, Madhavan S, Banerjee A. Pyruvate Oxidase as a Key Determinant of Pneumococcal Viability during Transcytosis across Brain Endothelium. J Bacteriol 2021;203:e0043921. [PMID: 34606370 DOI: 10.1128/JB.00439-21] [Reference Citation Analysis]
3 Anil A, Banerjee A. Pneumococcal Encounter With the Blood-Brain Barrier Endothelium. Front Cell Infect Microbiol 2020;10:590682. [PMID: 33224900 DOI: 10.3389/fcimb.2020.590682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Subramanian K, Iovino F, Tsikourkitoudi V, Merkl P, Ahmed S, Berry SB, Aschtgen MS, Svensson M, Bergman P, Sotiriou GA, Henriques-Normark B. Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease. EMBO Mol Med 2020;12:e12695. [PMID: 32985105 DOI: 10.15252/emmm.202012695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Subramanian K, Henriques-Normark B, Normark S. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen. Cell Microbiol 2019;21:e13077. [PMID: 31251447 DOI: 10.1111/cmi.13077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
6 Panagiotou S, Chaguza C, Yahya R, Audshasai T, Baltazar M, Ressel L, Khandaker S, Alsahag M, Mitchell TJ, Prudhomme M, Kadioglu A, Yang M. Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity. Sci Rep 2020;10:17313. [PMID: 33057054 DOI: 10.1038/s41598-020-73454-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Iovino F, Nannapaneni P, Henriques-Normark B, Normark S. The impact of the ancillary pilus-1 protein RrgA of Streptococcus pneumoniae on colonization and disease. Mol Microbiol 2020;113:650-8. [PMID: 32185835 DOI: 10.1111/mmi.14451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Le Guennec L, Coureuil M, Nassif X, Bourdoulous S. Strategies used by bacterial pathogens to cross the blood-brain barrier. Cell Microbiol 2020;22:e13132. [PMID: 31658405 DOI: 10.1111/cmi.13132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
9 Pereira JM, Xu S, Leong JM, Sousa S. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Front Immunol 2022;13:878244. [DOI: 10.3389/fimmu.2022.878244] [Reference Citation Analysis]
10 Badgujar DC, Anil A, Green AE, Surve MV, Madhavan S, Beckett A, Prior IA, Godsora BK, Patil SB, More PK, Sarkar SG, Mitchell A, Banerjee R, Phale PS, Mitchell TJ, Neill DR, Bhaumik P, Banerjee A. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle. PLoS Pathog 2020;16:e1009016. [PMID: 33216805 DOI: 10.1371/journal.ppat.1009016] [Reference Citation Analysis]
11 Feldman C, Normark S, Henriques‐normark B, Anderson R. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community‐acquired pneumonia. J Intern Med 2019;285:635-52. [DOI: 10.1111/joim.12875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Li W, Yin Y, Meng Y, Zhou H, Ma Z, Lin H, Fan H. Proteomic analysis of bEnd.3 cells infected with wild-type and stk-deficient strains of Streptococcus suis serotype 2 reveals protein and pathway regulation. J Proteomics 2021;230:103983. [PMID: 32961345 DOI: 10.1016/j.jprot.2020.103983] [Reference Citation Analysis]
13 Davis KM. For the Greater (Bacterial) Good: Heterogeneous Expression of Energetically Costly Virulence Factors. Infect Immun 2020;88:e00911-19. [PMID: 32041785 DOI: 10.1128/IAI.00911-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Bello C, Smail Y, Sainte-Rose V, Podglajen I, Gilbert A, Moreira V, Chrétien F, Cohen Salmon M, Tran Van Nhieu G. Role of astroglial Connexin 43 in pneumolysin cytotoxicity and during pneumococcal meningitis. PLoS Pathog 2020;16:e1009152. [PMID: 33370401 DOI: 10.1371/journal.ppat.1009152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Harrison MA, Kaur H, Wren BW, Dawson LF. Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage. Front Cell Infect Microbiol 2021;11:757599. [PMID: 34778108 DOI: 10.3389/fcimb.2021.757599] [Reference Citation Analysis]
16 Shenoy AT, Beno SM, Brissac T, Bell JW, Novak L, Orihuela CJ. Severity and properties of cardiac damage caused by Streptococcus pneumoniae are strain dependent. PLoS One 2018;13:e0204032. [PMID: 30216364 DOI: 10.1371/journal.pone.0204032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
17 Ogawa M, Takada N, Shizukuishi S, Tomokiyo M, Chang B, Yoshida M, Kakuta S, Tanida I, Ryo A, Guan JL, Takeyama H, Ohnishi M. Streptococcus pneumoniae triggers hierarchical autophagy through reprogramming of LAPosome-like vesicles via NDP52-delocalization. Commun Biol 2020;3:25. [PMID: 31932716 DOI: 10.1038/s42003-020-0753-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Sundaresh B, Xu S, Noonan B, Mansour MK, Leong JM, van Opijnen T. Host-informed therapies for the treatment of pneumococcal pneumonia. Trends Mol Med 2021:S1471-4914(21)00189-1. [PMID: 34376327 DOI: 10.1016/j.molmed.2021.07.008] [Reference Citation Analysis]
19 van de Beek D, Brouwer MC, Koedel U, Wall EC. Community-acquired bacterial meningitis. Lancet 2021:S0140-6736(21)00883-7. [PMID: 34303412 DOI: 10.1016/S0140-6736(21)00883-7] [Reference Citation Analysis]
20 Reinoso-Vizcaíno NM, Cian MB, Cortes PR, Olivero NB, Hernandez-Morfa M, Piñas GE, Badapanda C, Rathore A, Perez DR, Echenique J. The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells. PLoS Pathog 2020;16:e1008761. [PMID: 32790758 DOI: 10.1371/journal.ppat.1008761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]